Table of Contents


COMPANY OVERVIEW AND KEY FACTS
PARTNERSHIP
--Partnership - Overview
--Partnership - Deal reports
CAPITAL RAISING
--Capital Raising - Overview
--Capital Raising - Deal reports
DIVESTMENTS
--Divestments - Overview
--Divestments - Deal reports
PRIVATE EQUITY & OWNERSHIP
--Private Equity and Ownership - Overview
--Private Equity and Ownership - Deal reports

APPENDIX
--About MarketLine Financial Deals Database
--Deal Definition and Methodology
--About MarketLine
--MarketLine Professional Services Knowledge Center


List of Tables


--Pharming Group N.V. activity by deal type - volume (2012 -YTD2016)
--Pharming Group N.V. legal advisor ranking by value ($m)
--Top Deals(2012 -YTD2016)
--Pharming Group N.V. targets and partners (2012 -YTD2016)
--Pharming Group N.V. partnership volume and value trend (2012-YTD2016)
--Pharming Group N.V. partnership trend by key deal type (2012-YTD2016)
--Pharming Group N.V. capital raising volume and value trend (2012-YTD2016)
--Pharming Group N.V. capital raising by deal type (2012-YTD2016)
--Pharming Group N.V. divestments volume and value trend (2012-YTD2016)
--Pharming Group N.V. divestments activity by geography (2012-YTD2016)
--Pharming Group N.V. private equity and ownership volume and value trend (2012-YTD2016)
--Pharming Group N.V. private equity and ownership activity by deal type (2012-YTD2016)


List of Figures


--Pharming Group N.V. activity by deal type - volume (2012-YTD2016)
--Pharming Group N.V. partnership volume and value trend (2012-YTD2016)
--Pharming Group N.V. partnership trend by key deal type (2012-YTD2016)
--Pharming Group N.V. capital raising volume and value trend (2012-YTD2016)
--Pharming Group N.V. capital raising by deal type (2012-YTD2016)
--Pharming Group N.V. divestments volume and value trend (2012-YTD2016)
--Pharming Group N.V. divestments by geography (2012-YTD2016)
--Pharming Group N.V. private equity and ownership volume and value trend (2012-YTD2016)
--Pharming Group N.V. private equity and ownership by deal type (2012-YTD2016)